Suppr超能文献

肝细胞癌中的血管生成拟态促成门静脉侵犯。

Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion.

作者信息

Jue Chen, Zhifeng Wu, Zhisheng Zhang, Lin Cui, Yayun Qian, Feng Jin, Hao Gu, Shintaro Ishikawa, Hisamitsu Tadashi, Shiyu Guo, Yanqing Liu

机构信息

Institution of Integrated Traditional Chinese and Western Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, China.

Department of Oncology, The Second People's Hospital of Taizhou Affiliated to Yangzhou University, Taizhou, Jiangsu, China.

出版信息

Oncotarget. 2016 Nov 22;7(47):77987-77997. doi: 10.18632/oncotarget.12867.

Abstract

Portal vein invasion (PVI) is common in hepatocellular carcinoma (HCC) and largely contributes to tumor recurrence after radical tumor resection or liver transplantation. Vasculogenic mimicry (VM) was an independent vascular system lined with tumor cells and associated with poor prognosis of HCC. The present study was conducted to evaluate the relationship between VM and portal vein invasion. A total of 44 HCC cases receiving anatomic liver resection were included in the study and were divided into groups with and without PVI. The prevalence of VM in each group was examined by CD34-PAS dual staining. The regulatory molecules of VM formation such as Notch1, Vimentin and matrix metalloproteinases (MMPs) were investigated by immunohistochemical staining. Analysis was performed to explore the association of PVI, VM and the VM regulatory molecules. PVI was found in 40.91% (18/44) cases and VM was found in 38.64% (17/44) cases in total samples. The incidence of VM was 72.22% (13/18) in PVI group while it was 15.38% (4/26) in non-PVI group (P<0.001), VM formation was positively correlated with PVI (r=0.574, P<0.001). The VM forming regulatory molecules such as Notch1, Vimentin, MMP-2 and MMP-9 were found to be correlated with PVI in HCC patients. Taken together, our results suggested that VM formation, alone with its regulatory molecules, is the promoting factor of PVI in hepatocellular carcinoma.

摘要

门静脉侵犯(PVI)在肝细胞癌(HCC)中很常见,并且在很大程度上导致肿瘤根治性切除或肝移植后肿瘤复发。血管生成拟态(VM)是由肿瘤细胞衬里的独立血管系统,与HCC的不良预后相关。本研究旨在评估VM与门静脉侵犯之间的关系。本研究共纳入44例行解剖性肝切除的HCC病例,并分为有或无PVI组。通过CD34-PAS双重染色检测每组中VM的发生率。通过免疫组织化学染色研究VM形成的调节分子,如Notch1、波形蛋白和基质金属蛋白酶(MMPs)。进行分析以探讨PVI、VM和VM调节分子之间的关联。在全部样本中,40.91%(18/44)的病例发现有PVI,38.64%(17/44)的病例发现有VM。PVI组中VM的发生率为72.22%(13/18),而非PVI组为15.38%(4/26)(P<0.001),VM形成与PVI呈正相关(r=0.574,P<0.001)。发现VM形成调节分子如Notch1、波形蛋白、MMP-2和MMP-9与HCC患者的PVI相关。综上所述,我们的结果表明,VM形成及其调节分子是肝细胞癌中PVI的促进因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1f/5363638/470c7a81342b/oncotarget-07-77987-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验